
Nuvectis Pharma’s Upcoming Presentation at the 37th Annual Roth Conference: Insights into Their Latest Pharmaceutical Developments
Nuvectis Pharma’s CEO to Speak at 37th Annual Roth Conference FORT LEE, NJ, March 14, 2025 – Nuvectis Pharma, Inc., a pioneering biopharmaceutical company dedicated to the advancement of precision medicines for the treatment of serious conditions in oncology, announced that Ron Bentsur, Chairman and CEO, will participate in a fireside chat at the 37th…